Pheast Therapeutics
PrivateLast Round
Series A
Extension
Oct 15, 2025
Total Funding Raised
$100.6M
Company Overview
Pheast Therapeutics is a biotechnology company developing novel innate immune checkpoint inhibitors to enhance macrophage-mediated clearance of tumor cells in aggressive cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pheast Therapeutics Comparables
Compare Pheast Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoC4, Inc. | 82% | |
| DEM BioPharma | 80% | |
| Gilead Sciences | 79% | |
Pheast Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 15, 2025 | ||||
| Series A | Apr 26, 2022 |
Key People
Founding team and executive leadership
Pheast Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series A |
| Catalio Capital Management | Series A |
| ARCH Venture Partners | Series A |
| Alexandria Venture Investments | Series A |
| Stanford University's Presidential Venture Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2022
$76M round led by ARCH Venture Partners and Catalio Capital Management.
Pheast Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pheast Therapeutics's valuation, stock price, and market status.